Detalles de la búsqueda
1.
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial.
Ann Oncol
; 34(10): 907-919, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467930
2.
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
Ann Oncol
; 30(8): 1321-1328, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125062
3.
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC).
Ann Oncol
; 28(10): 2451-2457, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961841
4.
Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients.
Clin Transl Oncol
; 22(8): 1390-1398, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31916017
5.
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.
Lung Cancer
; 133: 83-87, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31200833
6.
DNA repair protein expression in resected NSCLC: a different predictive value for platinum benefit in adenocarcinoma versus squamous-cell carcinoma?
Ann Oncol
; 23(9): 2211-2214, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22684743
7.
Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches.
Lung Cancer
; 106: 70-75, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28285697
8.
Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
Lung Cancer
; 96: 1-6, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27133741
9.
Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient.
Pulmonology
; 26(1): 49-50, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31401029
10.
Corrigendum to "Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches" [Lung Cancer 106 (2017) 70-75].
Lung Cancer
; 117: 80, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29398170
Resultados
1 -
10
de 10
1
Próxima >
>>